We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
164 hedge funds and large institutions have $708M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 30 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
137% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 30
73% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 22
5% more funds holding
Funds holding: 156 → 164 (+8)
1% more capital invested
Capital invested by funds: $700M → $708M (+$8.18M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
54% less call options, than puts
Call options by funds: $4.41M | Put options by funds: $9.51M
Holders
164
Holders Change
+8
Holders Change %
+5.13%
% of All Funds
4.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
71
Reduced
30
Closed
22
Calls
$4.41M
Puts
$9.51M
Net Calls
-$5.09M
Net Calls Change
-$9.05M
Top Buyers
| 1 |
BlackRock
New York
|
+$102M |
| 2 |
State Street
Boston,
Massachusetts
|
+$36.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$30.9M |
| 4 |
O
OrbiMed
New York
|
+$16.9M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$14.5M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$2.31M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$2.27M |
| 3 |
Citigroup
New York
|
-$2.2M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.88M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.74M |
